Canada markets close in 2 hours 59 minutes

Henan Lingrui Pharmaceutical Co., Ltd. (600285.SS)

Shanghai - Shanghai Delayed Price. Currency in CNY
Add to watchlist
24.39+0.42 (+1.75%)
At close: 03:00PM CST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
3,431,871
3,311,473
3,001,862
2,693,511
2,331,577
Cost of Revenue
921,155
884,387
832,114
692,993
538,403
Gross Profit
2,510,717
2,427,085
2,169,748
2,000,518
1,793,175
Operating Expenses
Research Development
108,840
109,652
125,066
86,206
97,763
Selling General and Administrative
1,587,852
1,550,241
1,484,493
1,347,541
1,227,553
Total Operating Expenses
1,856,752
1,817,406
1,740,136
1,596,426
1,458,464
Operating Income or Loss
653,965
609,679
429,612
404,091
334,711
Interest Expense
-2,400
-179.793
774.6247
1,503
1,104
Income Before Tax
703,911
653,044
517,035
413,351
364,201
Income Tax Expense
89,647
84,928
51,730
50,852
39,819
Income from Continuing Operations
614,264
568,116
465,305
362,500
324,382
Net Income
614,242
568,109
465,305
361,543
325,489
Net Income available to common shareholders
614,242
568,109
465,305
361,543
325,489
Basic EPS
0.93
1.01
0.84
0.65
0.57
Diluted EPS
0.93
1.00
0.82
0.64
0.57
Basic Average Shares
563,683
561,373
556,584
556,219
568,044
Diluted Average Shares
564,820
566,410
568,137
566,681
568,044